T
BLFS icon

TCWP’s BioLife Solutions BLFS Stock Holding History

TCWP’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-108
Closed -$2K – 455
2022
Q1 		$2K Buy
+108
New +$2.84K ﹤0.01% 1287

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TCWP's BLFS Position: Q2 2022 in Review

TCWP sold out of BioLife Solutions (BLFS) in Q2 2022, closing a stake of 108 shares — an estimated $2K sold.

TCWP first reported a position in BLFS in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 160 funds tracked by Wall St. Rank hold BLFS as of Q2 2022.

  • TCWP reported no remaining BioLife Solutions position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 108 BioLife Solutions shares in Q2 2022, an estimated $2K.
  • TCWP first reported a position in BioLife Solutions in Q1 2022 and held it in 1 quarter.
  • TCWP's BioLife Solutions position peaked at $2K in Q1 2022.
  • 160 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.